CTT Pharmaceutical delays third-quarter financial report
CTTH•CTT Pharmaceutical Holdings delayed its Form 10-Q for the quarter ended September 30, 2026, citing unreasonable effort or expense. It expects to file within the five-calendar-day extension period and anticipates no significant change in operating results from the year-earlier period.
1. Filing delay
CTT Pharmaceutical Holdings delayed its Form 10-Q for the period ended September 30, 2026, citing unreasonable effort or expense. The company expects to file within the five-calendar-day extension period and does not anticipate a significant change in operating results from the corresponding year-earlier period.




